Abbott Laboratories (ABT) CFO uses 7,441 shares to cover tax withholding

Rhea-AI Filing Summary

Abbott Laboratories EVP and CFO Philip P. Boudreau reported a tax-related share disposition. On February 27, 2026, 7,441 common shares were surrendered at $116.26 per share to cover tax withholding obligations, a non-open-market transaction. After this, he directly held 71,172 common shares and indirectly held 366 shares through a Profit Sharing Trust as of that date.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Boudreau Philip P

Role EVP AND CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common shares without par value	7,441	$116.26	$865K
holding	Common shares without par value	--	--	--

Holdings After Transaction: Common shares without par value — 71,172 shares (Direct); Common shares without par value — 366 shares (Indirect, Profit Sharing Trust)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boudreau Philip P

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK IL 60064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP AND CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares without par value	02/27/2026		F		7,441	D	$116.26	71,172	D
Common shares without par value								366(1)	I	Profit Sharing Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2026.

	/s/ Philip P. Boudreau by Jessica H. Paik, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Abbott Laboratories (ABT) report for Philip P. Boudreau?

Abbott Laboratories reported that EVP and CFO Philip P. Boudreau surrendered 7,441 common shares on February 27, 2026. The shares were used to satisfy tax withholding obligations, rather than being sold on the open market, and were priced at $116.26 per share.

Was the Abbott (ABT) insider transaction an open-market sale of shares?

No, the transaction was not an open-market sale. Philip P. Boudreau’s 7,441 shares were disposed of as a tax-withholding transaction, coded “F,” meaning shares were delivered to cover tax liabilities rather than sold to public market buyers.

How many Abbott Laboratories (ABT) shares does Philip P. Boudreau hold after the transaction?

After the February 27, 2026 tax-withholding disposition, Philip P. Boudreau directly held 71,172 Abbott common shares. He also indirectly held 366 additional shares through a Profit Sharing Trust, reflecting his remaining reported ownership positions on that date.

What does transaction code F mean in the Abbott (ABT) Form 4 filing?

Transaction code F indicates a tax-withholding disposition, where shares are delivered to pay the exercise price or related tax liabilities. In this case, 7,441 Abbott common shares were used to satisfy tax obligations, not to execute a voluntary open-market sale.

What is the Profit Sharing Trust mentioned in the Abbott (ABT) Form 4?

The Profit Sharing Trust represents an indirect ownership vehicle holding Abbott shares for the insider. As of February 27, 2026, 366 Abbott common shares were held in the Abbott Laboratories Stock Retirement Trust, reported as an indirect holding for Philip P. Boudreau.